Compare CYTK & DDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYTK | DDS |
|---|---|---|
| Founded | 1997 | 1938 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Department/Specialty Retail Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 9.2B |
| IPO Year | 2004 | N/A |
| Metric | CYTK | DDS |
|---|---|---|
| Price | $62.41 | $684.16 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 16 | 3 |
| Target Price | $82.38 | ★ $511.33 |
| AVG Volume (30 Days) | ★ 2.2M | 150.1K |
| Earning Date | 02-26-2026 | 02-24-2026 |
| Dividend Yield | N/A | ★ 4.58% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 36.93 |
| Revenue | $87,211,000.00 | ★ $6,625,563,000.00 |
| Revenue This Year | $346.43 | $1.30 |
| Revenue Next Year | $57.69 | $0.57 |
| P/E Ratio | ★ N/A | $18.44 |
| Revenue Growth | ★ 2609.26 | N/A |
| 52 Week Low | $29.31 | $282.24 |
| 52 Week High | $70.98 | $741.98 |
| Indicator | CYTK | DDS |
|---|---|---|
| Relative Strength Index (RSI) | 49.43 | 59.98 |
| Support Level | $62.05 | $644.28 |
| Resistance Level | $66.59 | $669.69 |
| Average True Range (ATR) | 2.97 | 24.97 |
| MACD | 0.09 | 4.64 |
| Stochastic Oscillator | 33.47 | 94.27 |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Dillard's Inc is an American fashion apparel, cosmetics, and home furnishings retailer. Its stores offer a large variety of merchandise and feature products from both national and exclusive brand sources. The company also operates a general contracting construction company, CDI Contractors. CDI Contractors' business includes constructing and remodelling stores for Dillards. The merchandise selections include exclusive brand merchandise such as Antonio Melani, Gianni Bini, Daniel Cremieux, Roundtree & Yorke, and private-label merchandise, among others. The company operates in two business segments; Retail Operations and Construction. The Retail Operations segment generates maximum revenue for the company.